These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28805036)

  • 21. Utility of Frequency Domain Optical Coherence Tomographic Evaluation of Angiographically Optimized Stented Lesions.
    Agrawal M; Hakeem A; Ahmed Z; Uretsky BF
    J Invasive Cardiol; 2016 Mar; 28(3):94-7. PubMed ID: 26945250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
    Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical coherence tomography analysis of the stenting of saphenous vein graft (SOS) Xience V Study: use of the everolimus-eluting stent in saphenous vein graft lesions.
    Papayannis AC; Michael TT; Yangirova D; Abdel-Karim AR; Kohlhaas J; Mahmood A; Addo T; Haagen D; Makke L; Roesle M; Rangan B; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2012 Aug; 24(8):390-4. PubMed ID: 22865309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography.
    Ohtani H; Kimura S; Sugiyama T; Hishikari K; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hikita H; Ashikaga T; Takahashi A; Isobe M
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):177-186. PubMed ID: 27761750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immediate results of bifurcational stenting assessed with optical coherence tomography.
    Viceconte N; Tyczynski P; Ferrante G; Foin N; Chan PH; Barrero EA; Di Mario C
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):519-28. PubMed ID: 23024054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation.
    Jia H; Hu S; Liu H; Zhu Y; Zhe CY; Li L; Mustafina I; Hou J; Zhang S; Yu B
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):582-591. PubMed ID: 28318139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between post-stent strut apposition and follow-up strut coverage assessed by a contour plot optical coherence tomography analysis.
    Kim JS; Ha J; Kim BK; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Interv; 2014 Jun; 7(6):641-51. PubMed ID: 24835329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
    Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
    Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular Response to Experimental Stent Malapposition and Under-Expansion.
    O'Brien CC; Lopes AC; Kolandaivelu K; Kunio M; Brown J; Kolachalama VB; Conway C; Bailey L; Markham P; Costa M; Ware J; Edelman ER
    Ann Biomed Eng; 2016 Jul; 44(7):2251-60. PubMed ID: 26732391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-year optical coherence tomography findings in patients with late and very-late stent thrombosis treated with intravascular imaging guided percutaneous coronary intervention.
    Ñato M; Gomez-Lara J; Romaguera R; Roura G; Ferreiro JL; Teruel L; Gracida M; Fuentes L; Vandeloo B; Gomez-Hospital JA; Cequier A
    Int J Cardiovasc Imaging; 2018 Oct; 34(10):1511-1520. PubMed ID: 29790037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of Earlier Versus Delayed Presentation of Very Late Drug-Eluting Stent Thrombosis: An Optical Coherence Tomographic Study.
    Lee SY; Ahn JM; Mintz GS; Hur SH; Choi SY; Kim SW; Cho JM; Hong SJ; Kim JW; Hong YJ; Lee SG; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Vascular Responses to New-Generation Drug-Eluting Stenting According to Clinical Presentation: Three-Month Optical Coherence Tomographic Study.
    Lee SJ; Hong SJ; Kim BK; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Angiology; 2021 Apr; 72(4):381-391. PubMed ID: 33342226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optical coherence tomography visualization of stent deformation with subsequent thrombus adhesion at very early phase after everolimus-eluting stent implantation: a case report.
    Yamamura S; Fujisue K; Tsujita K; Sakamoto K; Miyazaki Y; Kaikita K; Hokimoto S; Ogawa H
    BMC Cardiovasc Disord; 2016 May; 16():116. PubMed ID: 27245071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation.
    Hong SJ; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2015 Nov; 56(6):1538-44. PubMed ID: 26446634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of late stent malapposition after drug-eluting stent implantation on long-term clinical outcomes.
    Im E; Lee SY; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Atherosclerosis; 2019 Sep; 288():118-123. PubMed ID: 31357039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study.
    Guagliumi G; Sirbu V; Bezerra H; Biondi-Zoccai G; Fiocca L; Musumeci G; Matiashvili A; Lortkipanidze N; Tahara S; Valsecchi O; Costa M
    JACC Cardiovasc Interv; 2010 Jun; 3(6):680-7. PubMed ID: 20630463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal Trends in Strut-Level Optical Coherence Tomography Evaluation of Coronary Stent Coverage: A Systematic Review and Meta-Analysis.
    Lee KS; Lee JZ; Hsu CH; Husnain M; Riaz H; Riaz IB; Thai H; Cassese S; Finn A; Samady H; Byrne RA
    Catheter Cardiovasc Interv; 2016 Dec; 88(7):1083-1093. PubMed ID: 26708687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
    Vesga B; Hernandez H; Moncada M; Gasior P; Higuera S; Dager A; Arana C; Delgado JA; Généreux P; Maehara A; Granada JF
    Coron Artery Dis; 2017 Mar; 28(2):126-134. PubMed ID: 27879518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.